Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

Baricitinib successfully treated severe hair loss.

Antioxidants can block the cancer-fighting effects of doxorubicin.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

High ODC and low K1 and K10 may indicate early skin tumors in mice.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

A new therapy for a skin blistering condition has not been developed yet.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Cetuximab can cause unusual hair growth and hair loss.